Search research articles
Contact Us
Filters
Showing results (31-40 of 230) with videos related to
Page
of 23
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
April 7, 2009
Analyzing classical and alternative macrophage activation in macrophage/neutrophil-specific IL-4 receptor-alpha-deficient mice
Frank Brombacher, Berenice Arendse, Reagon Peterson, et al.
The Journal of Infectious Diseases
|
April 17, 2007
Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response
Toya Nath Baral, Patrick De Baetselier, Frank Brombacher, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 22, 2007
CD4+ T cell-specific deletion of IL-4 receptor alpha prevents ovalbumin-induced anaphylaxis by an IFN-gamma-dependent mechanism
Natalie Nieuwenhuizen, De'Broski R Herbert, Andreas L Lopata, et al.
Allergy
|
November 30, 2019
Therapeutic and prophylactic deletion of IL-4Ra-signaling ameliorates established ovalbumin induced allergic asthma
Jermaine Khumalo, Frank Kirstein, Martyna Scibiorek, et al.
Plos Biology
|
November 1, 2018
The Foxp3+ regulatory T-cell population requires IL-4Rα signaling to control inflammation during helminth infections
Nada Abdel Aziz, Justin Komguep Nono, Thabo Mpotje, et al.
Scientific Reports
|
April 13, 2018
Author Correction: House dust mite induced allergic airway disease is attenuated in CD11c<sup>cre</sup>IL-4Rα<sup>-/l</sup>°<sup>x</sup> mice
Natalie Eva Nieuwenhuizen, Frank Kirstein, Jennifer Claire Hoving, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 26, 2006
Type 2 immune response associated with silicosis is not instrumental in the development of the disease
Pierre Misson, Frank Brombacher, Monique Delos, et al.
Microorganisms
|
July 26, 2020
Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?
Raphael Taiwo Aruleba, Katharine C Carter, Frank Brombacher, et al.
Trends in Immunology
|
July 14, 2022
Type 2 immunity: a two-edged sword in schistosomiasis immunopathology
Nada Abdel Aziz, Fungai Musaigwa, Paballo Mosala, et al.
Plos Neglected Tropical Diseases
|
July 18, 2012
Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice
Anita Masic, Ramona Hurdayal, Natalie E Nieuwenhuizen, et al.
Page
of 23
Search research articles
Search
Showing results (31-40 of 230) with videos related to
Sort By:
Page
of 23
Methods in Molecular Biology (Clifton, N.J.)
|
April 7, 2009
Analyzing classical and alternative macrophage activation in macrophage/neutrophil-specific IL-4 receptor-alpha-deficient mice
Frank Brombacher, Berenice Arendse, Reagon Peterson, et al.
The Journal of Infectious Diseases
|
April 17, 2007
Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response
Toya Nath Baral, Patrick De Baetselier, Frank Brombacher, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 22, 2007
CD4+ T cell-specific deletion of IL-4 receptor alpha prevents ovalbumin-induced anaphylaxis by an IFN-gamma-dependent mechanism
Natalie Nieuwenhuizen, De'Broski R Herbert, Andreas L Lopata, et al.
Allergy
|
November 30, 2019
Therapeutic and prophylactic deletion of IL-4Ra-signaling ameliorates established ovalbumin induced allergic asthma
Jermaine Khumalo, Frank Kirstein, Martyna Scibiorek, et al.
Plos Biology
|
November 1, 2018
The Foxp3+ regulatory T-cell population requires IL-4Rα signaling to control inflammation during helminth infections
Nada Abdel Aziz, Justin Komguep Nono, Thabo Mpotje, et al.
Scientific Reports
|
April 13, 2018
Author Correction: House dust mite induced allergic airway disease is attenuated in CD11c<sup>cre</sup>IL-4Rα<sup>-/l</sup>°<sup>x</sup> mice
Natalie Eva Nieuwenhuizen, Frank Kirstein, Jennifer Claire Hoving, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 26, 2006
Type 2 immune response associated with silicosis is not instrumental in the development of the disease
Pierre Misson, Frank Brombacher, Monique Delos, et al.
Microorganisms
|
July 26, 2020
Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?
Raphael Taiwo Aruleba, Katharine C Carter, Frank Brombacher, et al.
Trends in Immunology
|
July 14, 2022
Type 2 immunity: a two-edged sword in schistosomiasis immunopathology
Nada Abdel Aziz, Fungai Musaigwa, Paballo Mosala, et al.
Plos Neglected Tropical Diseases
|
July 18, 2012
Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice
Anita Masic, Ramona Hurdayal, Natalie E Nieuwenhuizen, et al.
Page
of 23